Structure Info
- Chemspace ID
- CSSS00028216798 (In-Stock Screening Compounds)
- IUPAC Name
- 1-[4-(2-bromo-6-chloro-4-methylphenoxy)butyl]-1H-1,3-benzodiazole
- Mol formula
- C18H18BrClN2O
- Mol weight
- 394 Da
- Catalog Number(s)
- 7924658, CSC028216798, PB237556494, Z237479026
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 5.59
- Heavy atoms count
- 23
- Rotatable bond count
- 6
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.277
- Polar surface area (Å)
- 27
- Hydrogen bond acceptors count
- 2
- Hydrogen bond donors count
- 0
- Zoom the structure
- CSSS00028216798
Items Overall 17 items from 3 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd | 5 days | Ukraine To: | 90 | 1 mg | 74 | |
| Enamine Ltd | 5 days | Ukraine To: | 90 | 2 mg | 76 | |
| Enamine Ltd | 5 days | Ukraine To: | 90 | 5 mg | 82 | |
| Enamine Ltd | 5 days | Ukraine To: | 90 | 10 mg | 92 | |
| Enamine Ltd | 5 days | Ukraine To: | 90 | 20 mg | 111 | |
| UORSY | 5 days | Ukraine To: | 90 | 1 mg | 74 | |
| UORSY | 5 days | Ukraine To: | 90 | 2 mg | 76 | |
| UORSY | 5 days | Ukraine To: | 90 | 5 mg | 82 | |
| UORSY | 5 days | Ukraine To: | 90 | 10 mg | 92 | |
| UORSY | 5 days | Ukraine To: | 90 | 20 mg | 111 | |
| ChemBridge Corp. | 14 days | United States To: | 90 | 1 mg | 68 | |
| ChemBridge Corp. | 14 days | United States To: | 90 | 5 mg | 99 | |
| ChemBridge Corp. | 14 days | United States To: | 90 | 10 mg | 138 | |
| ChemBridge Corp. | 14 days | United States To: | 90 | 20 mg | 209 | |
| ChemBridge Corp. | 14 days | United States To: | 90 | 25 mg | 248 | |
| ChemBridge Corp. | 14 days | United States To: | 90 | 50 mg | 407 | |
| ChemBridge Corp. | 14 days | United States To: | 90 | 100 mg | 803 | |
Description: Name: 1-[4-(2-bromo-6-chloro-4-methylphenoxy)butyl]-1H-benzimidazole oxalate; Stereochemistry: achiral; Compound state: solid | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire